ABNORMAL COAGULATION CONTROL PLASMA-2 (ACCP-2)— 510(k) K895261

Name: FDA 510(k) clearance K895261
Creator: U.S. Food and Drug Administration
Published: 1989-10-06

Substantially Equivalent

Medical Diagnostic Technologies, Inc.

FDA 510(k) clearance K895261 for ABNORMAL COAGULATION CONTROL PLASMA-2 (ACCP-2), Substantially Equivalent on 1989-10-06. Applicant: Medical Diagnostic Technologies, Inc.. Device class: 2.

Clearance details

Applicant: Medical Diagnostic Technologies, Inc.
Product code: Code GGC
Device class: Class 2
Regulation: 21 CFR 864.5425
Advisory panel: Hematology
Date received: 1989-08-22
Decision date: 1989-10-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Ventura, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GGC

view all

K102552 — HEMOSIL LA POSITIVE CONTROL2011-04-05
K100103 — SPECIALTY ASSAYED CONTROL-22010-12-15
K062306 — PLASMACON N, PLASMACON L-1, PLASMACON L-22007-03-16
K061803 — STA - CONTROL LA 1+22006-07-28
K032804 — CRYOCHECK WEAK LUPUS POSITIVE CONTROL2003-11-03

More clearances from Medical Diagnostic Technologies, Inc.

view all

K062229 — CTC WORKSTATION, MODEL 22002006-09-11
K972209 — SPECTROLYSE HEPARIN (ANTI-IIA)1997-08-12
K963106 — CHROMOLIZE PAI-1 KIT1996-11-18
K960871 — SPECTROLYSE ANTITHROMBIN III (ANTI-XA)1996-08-14
K962489 — CHROMOLIZE TPA ASSAY KIT1996-07-31

Data sourced from openFDA. This site is unofficial and independent of the FDA.